The Cancer-Translational Nanotechnology Training (Cancer-TNT) Program is currently accepting postdoctoral fellowship applications.
The Cancer-Translational Nanotechnology Training (Cancer-TNT) Program, is a diverse and synergistic 3-year training program bringing together 25 faculty and 9 Departments from three schools to train the next generation of interdisciplinary leaders who will pursue challenges in cancer research and clinical translation. Cancer nanotechnology is a rapidly growing field that requires close interactions of researchers from disparate fields of science, such as chemistry, materials science, cancer biology, and medicine.
Postdoctoral trainees will cross train to develop interdisciplinary researchers in cancer nanotechnology translation. Our trainees' skill sets will bridge multiple disciplines such as chemistry, molecular biology, bioengineering, molecular imaging, nanoengineering, and clinical cancer medicine. Trainees will be able to advance cancer research, diagnosis, and management.
Eligibility:
- Applicants must have a MD or PhD degree
- At the time of the award, the candidate must be a US citizen, or a non-citizen national, or must have been lawfully admitted for permanent residence and possess an Alien Registration Card (1-151 or 1-551) or some other verification of legal admission as a permanent resident (See more information on trainee eligibility)
- Should not have more than 3 year postdoc or research industry experience prior to the start of the fellowship program
To Apply: http://med.stanford.edu/ctnt/apply.html
Application Deadline: August 1, 2018
